Vaxcyte, Inc. (PCVX)
54.87
-0.61
(-1.10%)
USD |
NASDAQ |
Mar 18, 13:53
Vaxcyte Market Cap : 7.897B for March 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Merck & Co., Inc. | 283.44B |
| Corcept Therapeutics, Inc. | 3.531B |
| Cytokinetics, Inc. | 7.692B |
| Rhythm Pharmaceuticals, Inc. | 5.932B |
| Sutro Biopharma, Inc. | 183.85M |
Market Cap Related Metrics
| PEG Ratio | -0.2044 |
| Price to Book Value | 2.941 |
| Price | 54.87 |
| Earnings Yield | -10.40% |
| PEGY Ratio | -0.2044 |